fibromyalgia |
026, 107 |
metabolic syndrome |
026 |
obesity |
026 |
pain pressure threshold |
026 |
anakinra |
146 |
canakinumab |
146 |
etanercept |
146 |
juvenile idiopathic arthritis |
146 |
tocilizumab |
146 |
anxiety |
038 |
fibromyalgia syndrome |
038 |
nesfatin-1 |
038 |
disease-modifying antirheumatic drug |
001 |
functional status |
001 |
psoriatic arthritis |
001 |
quality of life |
001 |
abatacept |
010 |
arashi score |
010 |
large joint |
010 |
rheumatoid arthritis |
010, 063 |
connective tissue diseases |
019 |
diagnosis |
019 |
interstitial lung disease |
019 |
screening |
019 |
vector |
019 |
velcro crackles |
019 |
juvenile systemic lupus erythematosus |
047 |
lupus nephritis |
047 |
nephritis activity |
047 |
urinary alpha chain of the interleukin-2 receptor |
047 |
cardiovascular disease risk |
063 |
heart disease |
063 |
knowledge of cardiovascular disease |
063 |
fibrosis |
129 |
immunoglobulin g4-related disease |
129 |
lumbar vertebral involvement |
129 |
ankylosing spondylitis |
056 |
choroid thickness |
056 |
infliximab |
056 |
optical coherence tomography |
056 |
retinal nerve fiber layer thickness |
056 |
b-cell activating factor |
072 |
biomarker |
072 |
sarcoidosis |
072 |
females |
120 |
qualitative study |
120 |
systemic lupus erythematosus |
120, 101, 089 |
autoimmune disease |
101 |
rheumatology |
101 |
vitamin d |
101 |
health perceptions |
089 |
health-related quality of life |
089 |
physical activity |
089 |
physical capacity |
089 |
depressive symptoms |
089 |
axial spondyloarthritis |
080 |
fluoroscopy |
080 |
intraarticular injection |
080 |
sacroiliac joint |
080 |
sacroiliitis |
080 |
carpal tunnel syndrome |
107 |
electrodiagnosis |
107 |
nerve compression syndrome |
107 |
paresthesia |
107 |
tarsal tunnel syndrome |
107 |
breast pain index |
114 |
mastalgia |
114 |
myofascial pain syndrome |
114 |